IMAC Holdings Q3 Sales $3.78M

IMAC Holdings (NASDAQ:BACK) reported $3.78 million in sales this quarter.

IMAC Holdings (NASDAQ:BACK) reported $3.78 million in sales this quarter.

Total
0
Shares
Related Posts
Read More

ARS Pharmaceuticals Submits Response For neffy Marketing Authorization Application To EMA’s CHMP And Enters License Agreement With CSL Seqirus For Commercialization Of neffy In Australia And New Zealand

CHMP opinion on neffy Marketing Authorization Application anticipated in the second quarter of 2024 Response addresses all issues previously identified by CHMP, and includes results from a repeat dose PK/PD study of

CSLLY

Read More

Earnings Preview: Iridex

  Iridex (NASDAQ:IRIX) is set to give its latest quarterly earnings report on Monday, 2022-08-15. Here's what investors need to know before the announcement. Analysts estimate that Iridex will report an earnings per share (EPS) of $-0.15.

IRIX